Showing results (251-260 of 391) with videos related to

Sort By:
Pageof 40
Journal of Theoretical Biology|July 12, 2016
A dynamical model for bark beetle outbreaksVlastimil Křivan, Mark Lewis, Barbara J Bentz, et al.
Elife|April 25, 2022
Retinoic acid-induced protein 14 controls dendritic spine dynamics associated with depressive-like behaviorsSoo Jeong Kim, Youngsik Woo, Hyun Jin Kim, et al.
Journal of Neuroinflammation|February 21, 2024
Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson's diseaseJae-Bong Kim, Yujeong Kim, Soo-Jeong Kim, et al.
General Physiology and Biophysics|August 17, 2016
Effects of exposure to extremely low-frequency electromagnetic fields on the differentiation of Th17 T cells and regulatory T cellsYun-Jung Lee, Kyeong Eun Hyung, Jong-Sun Yoo, et al.
The Journal of Biological Chemistry|April 22, 2004
Purinergic receptors coupled to intracellular Ca2+ signals and exocytosis in rat prostate neuroendocrine cellsJun Hee Kim, Joo Hyun Nam, Mean-Hwan Kim, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 3, 2019
Non-cell autonomous modulation of tyrosine hydroxylase by HMGB1 released from astrocytes in an acute MPTP-induced Parkinsonian mouse modelSoo Jeong Kim, Min Jeong Ryu, Jeongsu Han, et al.
Leukemia & Lymphoma|February 9, 2016
Metabolic characterization of imatinib-resistant BCR-ABL T315I chronic myeloid leukemia cells indicates down-regulation of glycolytic pathway and low ROS productionByung Woong Ko, Jeongsu Han, Jun Young Heo, et al.
Annals of Hematology|May 12, 2020
Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphomaYu Ri Kim, Sun Och Yoon, Soo-Jeong Kim, et al.
Nature Communications|June 16, 2023
Ratiometric measurement of MAM Ca2+ dynamics using a modified CalfluxVTNEunbyul Cho, Youngsik Woo, Yeongjun Suh, et al.
Journal of Korean Medical Science|April 7, 2016
Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based RegimensShin Young Hyun, Sang Hoon Han, Soo-Jeong Kim, et al.
Pageof 40